Enanta Pharmaceuticals (ENTA) Capital Expenditures (QoQ) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -89.51% |
| Dec 31, 2025 | -98.76% |
| Sep 30, 2025 | 216.31% |
| Jun 30, 2025 | -489.56% |
| Mar 31, 2025 | -70.98% |
| Dec 31, 2024 | -24.17% |
| Sep 30, 2024 | 191.14% |
| Jun 30, 2024 | 137.47% |
| Mar 31, 2024 | 111.94% |
| Dec 31, 2023 | -42.47% |
| Sep 30, 2023 | -36.40% |
| Jun 30, 2023 | -9.74% |
| Mar 31, 2023 | -24.49% |
| Dec 31, 2022 | 498.86% |
| Sep 30, 2022 | 109.96% |
| Jun 30, 2022 | -35.81% |
| Mar 31, 2022 | 750.00% |
| Dec 31, 2021 | -93.73% |
| Sep 30, 2021 | 343.05% |
| Jun 30, 2021 | -332.31% |
| Mar 31, 2021 | -30.85% |
| Dec 31, 2020 | 269.37% |
| Sep 30, 2020 | -158.42% |
| Jun 30, 2020 | 150.13% |
| Mar 31, 2020 | -177.66% |
| Dec 31, 2019 | 64.86% |
| Sep 30, 2019 | -86.73% |
| Jun 30, 2019 | 40.52% |
| Mar 31, 2019 | 21.70% |
| Dec 31, 2018 | 2,932.56% |
| Sep 30, 2018 | 103.62% |
| Jun 30, 2018 | -203.76% |
| Mar 31, 2018 | 931.53% |
| Dec 31, 2017 | -52.56% |
| Sep 30, 2017 | -68.42% |
| Jun 30, 2017 | 28.20% |
| Mar 31, 2017 | -39.35% |
| Dec 31, 2016 | 125.85% |
| Sep 30, 2016 | -701.31% |
| Jun 30, 2016 | -59.48% |
| Mar 31, 2016 | -31.13% |
| Dec 31, 2015 | 39.05% |
| Sep 30, 2015 | 295.00% |
| Jun 30, 2015 | 300.00% |
| Mar 31, 2015 | -60.94% |
| Dec 31, 2014 | -47.22% |
| Sep 30, 2014 | 28.31% |
| Jun 30, 2014 | 168.09% |
| Mar 31, 2014 | 487.50% |
| Dec 31, 2013 | -88.12% |
| Sep 30, 2013 | 288.46% |
| Jun 30, 2013 | -84.75% |
| Mar 31, 2013 | 3,000.00% |
| Dec 31, 2012 | -90.09% |
| Sep 30, 2012 | 136.17% |